1. No category

12 MARCH 2015, THURSDAY
POSTER NO
PRESENTER
TITLE
PP - 1006
Xu Li
PP - 1010
Mohamed Alboraie
ACCEPTABILITY, RELIABILITY AND APPLICABILITY OF LIVER BIOPSY AND NONINVASIVE METHODS FOR ASSESSMENT OF HEPATIC
FIBROSIS AND CIRRHOSIS AMONG HEPATOLOGISTS; A WEB BASED SURVEY
PP - 1011
Mohamed Alboraie
VALIDATION OF HEPA-INDEX AS A NON-INVASIVE BIOMARKERS PANEL FOR ASSESSMENT OF HEPATIC FIBROSIS IN EGYPTIANS
WITH CHRONIC HEPATITIS C
PP - 1016
Aq Taguba
PP - 1017
Sergei Malov
THE EFFECTIVENESS OF ANTIVIRAL THERAPY IN THE PATIENTS WITH CHRONIC HEPATITIS C IN CAUCASIANS AND ASIANS,
CONSIDERING POLYMORPHISM OF INTERLEUKIN-28B GENE OF POPULATION
PP - 1018
Raksawan Poonkhum
COLLAGEN ARRANGEMENT IN SPACE OF DISSE CORRELATES WITH FLUID FLOW IN NORMAL AND CIRRHOTIC RAT LIVERS
PP - 1021
Naota Taura
PP - 1022
Chang Hyeong Lee
THE EFFECTS OF ELECTRO-ACUPUNCTURE ON THE MUSLCE CRAMPS OF　LIVER CIRRHOSIS　PATIENTS: PILOT
STUDY
PP - 1023
Chang Hyeong Lee
THE EFFECTS OF ELECTRO-ACUPUNCTURE ON THE MUSLCE CRAMPS OF　LIVER CIRRHOSIS　PATIENTS: PILOT
STUDY
PP - 1026
Ming-Hua Zheng
ADJUVANT THERAPY FOR RESECTED HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
PP - 1029
Patrick Basu
CLINICAL OBSERVATION OF PLASMA EXCHANGE IN THE TREATMENT OF LIVER FAILURE IN NORTHEAST CHINA
STATINS AS ADD-ON THERAPY FOR CHRONIC HEPATITIS C: A META-ANALYSIS
INSULIN RESISTANCE IS ASSOCIATED WITH ELEVATED SERUM ALPHA-FETOPROTEIN LEVELS IN PATIENTS WITH CHRONIC HEPATITIS
C
NOVEL COLONOSCOPY PREPARATION OF ORGANIC COCONUT WATER WITH MIRALAX AND DULCOLAX IN SPLIT DOSES FOR
DECOMPENSATED CIRRHOTICS. A RANDOMIZED DOUBLE BLINDED OPEN LABELLED CLINICAL PILOT SINGLE CENTERED
OBSERVATIONAL STUDY. COSMIC STUDY
PROSPECTIVE VALIDATION OF BAVENO V DEFINITIONS AND CRITERIA FOR FAILURE TO CONTROL BLEEDING IN PORTAL
HYPERTENSION
PP - 1034
Sun Young Ahn
PP - 1037
Nassıma Belabas
EPIDEMIOLOGICAL AND CLINICO-BIOLOGICAL ASPECTS OF THE POPULATION CO-INFECTED WITH HUMAN IMMUNODEFICIENCY
VIRUS AND HEPATITIS C VIRUS: REVIEW OF 22 CASES IN AN INFECTIOUS DISEASES UNIT.
PP - 1039
Nassıma Belabas
HUMAN IMMUNODEFICIENCY VIRUS - HEPATITIS C VIRUS CO-INFECTION AND OBSTACLES FOR THE INITIATION OF CONVENTIONAL
HEPATITIS C TREATMENT: EXPERIENCE OF AN INFECTIOUS DISEASES UNIT.
PP - 1043
Ahmet Uyanikoglu
PP - 1046
Khai Jing Ng
PP - 1047
Dr Vinit Shah.
PP - 1050
Takamasa Ohki
PP - 1052
Dr Vinit Shah.
SPECTRUM AND SHORT TERM OUTCOME OF RENAL IMPAIRMENT IN CIRRHOSIS.
PP - 1053
Rinkesh Bansal
IMPACT OF BISPHOSPHONATE SUPPLEMENTATION IN PATIENTS WITH OSTEOPOROSIS SECONDARY TO NON-CHOLEASTATIC LIVER
CIRRHOSIS
PP - 1059
Hasan Ali
PP - 1060
Hyeyoung Kim
RESPONSE GUIDED THERAPY FOR HEPATITIS C VIRUS RECURRENCE ON EARLY PROTOCOL BIOPSY AFTER LIVER TRANSPLANTATION
PP - 1062
Yasemin Durdu
NEVER GIVE UP, FIGHT WITH HEPATITIS C
CAN CIRRHOSIS CAUSE CARDIOMYOPATHY?
RISKS OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER CIRRHOSIS: A NATIONWIDE COHORT STUDY IN TAIWAN
PREDICTORS OF RESPONSE AND OUTCOME TO TERLIPRESSIN IN PATIENTS WITH HEPATORENAL SYNDROME
COMBINATION THERAPY WITH SORAFENIB AND TRANSARTERIAL CHEMOEMBOLIZATION (TACE) SIGNIFICANTLY PROLONGS
OVERALL SURVIVAL COMPARED TO TACE ALONE
CORRELATION BETWEEN SERUM HYALURONIC ACID AND FIBROSIS, STEATOSIS, NON ALCOHOLIC STEATOHEPATITIS AND
NECROINFLAMMATION IN CHRONIC HCV INFECTION
PP - 1065
İbrahim Hatemi
SERUM CA 125 LEVELS ARE SIGNIFICANTLY ELEVATED IN PATIENTS WITH LIVER CIRRHOSIS WITH ASCITES
PP - 1066
Byung Seok Lee
A CASE OF EXTRAHEPATIC METASTASIS OF HEPATOCELLULAR CARCINOMA TO THE PRONATOR QUADRATUS MUSCLE OF RT.
WRIST
PP - 1067
Cheng-Hsun Ho
DISTINCT EFFECACIES ON THE REVERSAL OF TGF-β1 AND ABERRANT IGG GLYCOSYLATION IN PATIENTS WITH LIVER
CIRRHOSIS BETWEEN ENTEVAVIR AND TELBIVUDINE
PP - 1071
George Sebastian Gherlan
COMBINED (IMAGING AND SERIC) NONINVASIVE SCORE FOR PREDICITING SIGNIFICANT LIVER FIBROSIS IN CHRONIC HEPATITIS C
PP - 1075
Ragesh Babu Thandasssery
HOW MUCH DO ROUTINE BLOOD TESTS TELL ABOUT LIVER FIBROSIS IN CHRONIC HEPATITIS C ?
PP - 1086
Mamun Al Mahtab
PP - 1088
Hong Shi
SEPSIS IS RARE AS ACUTE PRECIPITATING EVENT IN PATIENTS WITH HBV-RELATED ACUTE-ON-CHRONIC LIVER FAILURE
PP - 1089
Hong Shi
THE ACCURACY OF THE FIB-4 INDEX FOR THE DIAGNOSIS OF SIGNIFICANT FIBROSIS IN CHILDREN WITH CHRONIC HEPATITIS B
PP - 1092
Sayfullo Avezov
PP - 1094
Elif Sahin Horasan
MORTALITY RELATED RISK FACTORS FOR CULTURE POSITIVE-SPONTANEOUS BACTERIAL PERITONITIS
PP - 1097
Hitoshi Mochizuki
A PROSPECTIVE CONTROLLED TRIAL OF RADIOFREQUENCY ABLATION FOR HEPATOCELLULAR CARCINOMA PERFORMED BY TWO
HEPATOGASTROENTEROLOGISTS WITH DIFFERENT TRAINING BACKGROUNDS (4)
PP - 1104
Soo Hyun Yang
PROCALCITONIN IS A SURROGATE MARKER OF INFECTION IN CIRRHOSIS PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER
TRANSARTERIAL CHEMOEMBOLIZATION OR RADIOFREQUENCY THERAPY
SAFETY AND EFFICACY OF TELBIVUDINE IN PATIENTS WITH HEPATITIS B RELATED ACUTE ON CHRONIC LIVER FAILURE - INITIAL
EXPERIENCE FROM A TERTIARY CENTRE IN BANGLADESH
CLINICAL, BIOCHEMICAL AND MORPHOLOGICAL PECULIARITIES OF LIVER CIRRHOSIS DEPENDING ON ETIOLOGICAL VIRUS
PP - 1106
Myung Seok Lee
TREATMENT EFFICACY OF PEGYLATED INTERFERON PLUS RIBAVIRIN IN PATIENTS INFECTED WITH GENOTYPE 6 HEPATITIS C VIRUS
IN KOREA
PP - 1107
Eaum Seok Lee
GROWTH DIFFERENTIATION FACTOR-15 CAN PREDICTS SEVERITY OF CHRONIC LIVER DISEASE.
PP - 1109
Mamun Al Mahtab
PP - 1111
Hyun Young Woo
OUTCOMES OF YTTRIUM-90 RADIOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA FROM EARLY TO ADVANCED TUMOR
STAGES
PP - 1113
Surbhı Pande
POTENTIAL OF POSITRON EMISSION TOMOGRAPHY WITH FLUORINE-18-FLUORODEOXYGLUCOSE (FDG-PET) IN IDENTIFYING
RECURRENCE IN HEPATOCELLULAR CARCINOMA POST LIVER TRANSPLANTATION
PP - 1114
Youde Lıu
PP - 1121
Mohamed Kohla
IMPACT OF NITAZOXANIDE ON SUSTAINED VIROLOGIC RESPONSE (SVR) IN EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS C
GENOTYPE 4: A DOUBLE BLIND PLACEBO-CONTROLLED TRIAL
PP - 1123
Wonhyeong Park
HEPATITIS C VIRUS INFECTION AND RISK OF LYMPHOMA WHETHER EXPOSED TO AGENT ORANGE
PP - 1124
Bilgehan Aygen
PP - 1126
Won Il Jang
REPEATED STEREOTACTIC BODY RADIOTHERAPY FOR HEPATOCELLULAR CARCINOMA
PP - 1127
Won Il Jang
SURVIVAL ADVANTAGE WITH THE USE OF METFORMIN IN HEPATOCELLULAR CARCINOMA PATIENTS RECEIVING RADIOTHERAPY: A
PROPENSITY SCORE MATCHING ANALYSIS
PP - 1132
Gautam Ray
FACTORS INFLUENCING RESPONSE OF CHRONIC HEPATITIS C TO PEGINTERFERON AND RIBAVIRIN THERAPY IN INDIAN PATIENTS
SAFETY AND EFFICACY OF ELTROMBOPAG OLAMINE IN PATIENTS WITH THROMBOCYTOPENIA ON THE BACKGROUND OF
HEPATITIS C VIRUS RELATED CIRRHOSIS OF LIVER - INITIAL EXPERIENCE FROM A TERTIARY CENTRE IN BANGLADESH
THE PROTHROMBIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST-LI IS A GOOD DIAGNOSTIC FACTOR IN THE HBV RELATED
BCLC 0-B STAGE HEPATOCELLULAR CARCINOMA
RETREATMENT OF CHRONIC HEPATITIS C INFECTION WITH TELAPREVIR: PRELIMINARY RESULTS IN TURKEY
PP - 1134
Erdal Birol Bostancı
LIVING DONOR LIVER TRANSPLANTATION FOR GLYCOGEN STORAGE DISEASE TYPE IV; A CASE REPORT
PP - 1135
Sung Chang Gong
PP - 1136
M.B. Rokni
PP - 1146
Ennaliza Salazar
PP - 1147
Ye-Fa Yang
PP - 1152
Ennaliza Salazar
BROKEN HEART' IN ACUTE ON CHRONIC LIVER FAILURE
PP - 1154
Rajneesh Kumar
SUCCESSFUL TREATMENT OF POST RENAL TRANSPLANT HEPATITIS C WITH SOFUSBUVIR AND SIMEPRAVIR ONLY
PP - 1157
Xueping Yu
PP - 1158
Ahmet Uyanikoglu
DEMOGRAPHIC AND CLINIC CHARACTERISTICS OF CIRRHOTIC PATIENTS IN SANLIURFA, TURKEY
PP - 1159
Tomonari Okudaira
WHICH IS THE SUITABLE TREATMENT FOR ADVANCED HEPATOCELLULAR CARCINOMA WITH MAJOR PORTAL VEIN TUMOR
THROMBOSIS;SORAFENIB OR TRANSCATHETER ARTERIAL CHEMO-INFUSION?
PP - 1163
Mustafa Neamatallah
PP - 1166
Gian Carlo Carpio
THE MEANING OF THE GROSS TYPE IN THE ASPECTS OF CYTOKERATIN 19 POSITIVITY AND RESECTION MARGIN IN PATIENTS WITH
HEPATOCELLULAR CARCINOMA WHO UNDERWENT LIVER RESECTION
LIVER FLUKE DISEASE AND THE RISK OF CANCER AND CIRRHOSIS
BROKEN HEART' IN ACUTE ON CHRONIC LIVER FAILURE
TREATMENT OF PERIDUCTAL HEPATOCELLULAR CARCINOMA USING PERCUTANEOUS MICROWAVE ABLATION WITH INTRADUCTAL
COOLING OF THE CENTRAL BILE DUCT
ELEVATED TGF-β1/IL-23 PATHWAY IS ASSOCIATED WITH THE DISEASE SEVERITY OF HEPATITIS B VIRUS RELATED-LIVER
CIRRHOSIS
EPIDEMIOLOGICAL ASPECTS OF INTRAFAMILIAL SPREAD OF HCV INFECTION IN EGYPTIAN POPULATION: A PILOT STUDY
DEMOGRAPHIC PROFILE AND TREATMENT OUTCOMES OF FILIPINO PATIENTS WITH HEPATOCELLULAR CARCINOMA IN A LIVER
TUMOR REGISTRY
CORRELATION BETWEEN SERUM HYALURONIC ACID AND STEATOSIS, NON ALCOHOLIC STEATOHEPATITIS AND FIBROSIS IN
PATIENTS WITH CHRONIC HCV INFECTION
PP - 1169
Mohamad Helal
PP - 1174
Hiroyuki Kato
PP - 1176
Jie Chen
PP - 1179
Patrick Basu
PP - 1181
Kuo-Chin Chang
PP - 1185
Roxanne Mae Butal
PP - 1190
Sang Bong Ahn
PP - 1191
Etsushi Kawamura
PP - 1192
Chikage Nakano
PP - 1193
Muhammad Omar Qureshi
PP - 1202
Salman Shakeel
SERIAL SPIROMETRIC CHANGES IN PATIENTS ON INTERFERON THERAPY FOR HEPATITIS C VIRUS TREATMENT.
PP - 1209
Byung Seok Kim
PRE-ENDOSCOPIC CLINICAL CHARACTERISTICS OF VARICEAL AND NON-VARICEAL GASTROINTESTINAL BLEEDING IN THE PATIENTS
WITH LIVER CIRRHOSIS/CHRONIC LIVER DISEASE
FIFTY-TWO LESIONS OF ADVANCED OR TERMINAL STAGE HEPATOCELLULAR CARCINOMA CLASSIFIED BY THE BARCELONA CLINIC
LIVER CANCER CLASSIFICATION AND TREATED WITH THE CYBERKNIFE
LIVER TRANSPLANTATION
IMPACT OF CANNABIS IN DEVELOPING ESOPHAGEAL VARICES IN END STAGE LIVER DISEASE SECONDARY TO CHRONIC HEPATITIS C
(CHC). A RETROSPECTIVE STUDY.
A POLYMORPHISM IN IFNL3 IS AN INDEPENDENT RISK FACTOR DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AFTER
TREATMENT OF HCV INFECTION
PLATELET COUNT/ SPLEEN DIAMETER RATIO: NON-INVASIVE MARKER FOR PREDICTING BLEEDING FROM ESOPHAGEAL VARICES
TREATMENT OF CHRONIC HEPATITIS C IN END STAGE RENAL DISEASE PATIENTS TREATED BY DIALYSIS: MULTICENTER EXPERIENCE
IN KOREA
DANAPAROID SODIUM THROMBOLYTIC THERAPY FOLLOWED BY WARFARIN IN CIRRHOTIC PATIENTS WITH PORTAL VEIN
THROMBOSIS
EVALUATION OF THE CORRELATION AND DISCREPANCY IN THREE DIFFERENT SHEAR-WAVE BASED ULTRASOUND ELASTOGRAPHY
DEVICES
DAILY SINGLE-DOSE RIFAXIMIN FOR PREVENTION OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CHRONIC LIVER DISEASE.
PP - 1211
Engin Onan
THE IMPORTANCE OF CIRCULATING MIR-122 FOR HEPATOCELLULAR CARCINOMA
PP - 1216
Hsueh-Chou Lai
PP - 1217
Jihua Lu
PP - 1218
Mei-Hsuan Lee
PP - 1231
Ali Ghweil
PP - 1235
Harrys Torres
PP - 1245
Muharrem Coşkun
PP - 1247
Seo Young Yang
CLINICAL CHARACTERISTICS, EFFICACY AND SAFETY OF HCV PATIENTS AGED 70 YEARS OR OLDER TREATED WITH PEGYLATED
INTERFERON-αAND RIBAVIRIN
PP - 1248
Soo Hyun Yang
ASSOCIATION OF HEPATITIS C VIRUS INFECTION WITH DIABETES MELLITUS: FOCUS ON WHETHER EXPOSED TO AGENT ORANGE
PP - 1252
J-H. Kang
PP - 1253
Tansu Yamazhan
TRIPLE COMBINATION THERAPY EXPERIENCE IN RELAPSING CHRONIC HEPATITIS C PATIENTS
PP - 1256
Young Seok Kim
THE CORRELATION BETWEEN 25-HYDROXY VITAMIN D LEVEL AND LIVER FIBROSIS BY TRANSIENT ELASTOGRAPHY IN PATIENT WITH
COMPENSATED CHRONIC LIVER DISEASE
RISK OF LATE FINDING PRIMARY LIVER CANCER IN PATIENTS WITH PYOGENIC LIVER ABSCESS: A POPULATION-BASE COHORT STUDY
RELIABILITY OF A SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGINTERFERONα2B AND RIBAVIRIN: SEVEN-YEAR FOLLOW-UP IN CHINA
LIVER CIRRHOSIS RISK CALCULATOR FOR PATIENTS INFECTED WITH HEPATITIS C VIRUS
SERUM TUMOR MARKERS FOR DETECTION OF HEPATOCELLULAR CARCINOMA.
SAFETY AND TOLERABILITY OF DIFFERENT ANTIVIRAL REGIMENS FOR CHRONIC HEPATITIS C VIRUS INFECTION IN CANCER PATIENTS
RISK FACTORS FOR HEPATOCELLULAR CARCINOMA: A SINGLE CENTER EXPERIENCE
ACUTE HEPATITIS A OR E CAN TRIGGER THE DEVELOPMENT OF ACUTE ON CHRONIC LIVER FAILURE (AOCLF) IN SAPPORO, JAPAN.
PP - 1260
Jeong Han Kim
VALUE OF PLASMA NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN IN CIRRHOTIC PATIENTS AND HEPATOCELLULAR
CARCINOMA PATIENTS
PP - 1261
Young Seok Kim
CLINICAL VALIDATION OF A REVISED SUB-STAGING IN KOREAN PATIENT WITH INTERMEDIATE HEPATOCELLULAR CARCINOMA
(BCLC-B)
PP - 1268
İbrahim Hatemi
SERUM CA 125 LEVELS ARE SIGNIFICANTLY ELEVATED IN PATIENTS WITH LIVER CIRRHOSIS WITH ASCITES
PP - 1269
Salman Shakeel
ESOPHAGEAL VARICES DUE TO HEPATITIS C VIRUS- THE MOST FREQUENT ENDOSCOPIC FINDING IN UPPER GASTROINTESTINAL
BLEED IN PAKISTANI POPULATION
PP - 1272
Anupama Kalsekar
PP - 1273
Sudhir Maharshi
PP - 1275
Nauman Arif Jadoon
PRESENCE OF ANEMIA PREDICTS ADVANCED GRADE AT PRESENTATION IN PATIENTS WITH HEPATIC ENCEPHALOPATHY
PP - 1276
Nauman Arif Jadoon
CLINICAL PROFILE AND MROTALITY IN PATIENTS WITH HEPATOPULMONARY SYNDROME
PP - 1277
Nauman Arif Jadoon
CLINICAL PRESENTATION, ULTRASOUND FINDINGS, AND BIOCHEMICAL ABNORMALITIES IN DECOMPENSATED CIRRHOSIS: A
REVIEW OF 162 PATIENTS
PP - 1280
Ju-Yeon Cho
PREDICTIVE FACTORS FOR EARLY MASSIVE RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER RADIOFREQUENCY ABLATION
PP - 1281
Ju-Yeon Cho
TREATMENT OF HEPATOCELLULAR CARCINOMA IN CHILD-PUGH CLASS C LIVER CIRRHOSIS PATIENTS
PP - 1284
Js Lee
THE COMPARATIVE EFFICACY AND SAFETY OF DACLATASVIR (DCV) PLUS ASUNAPREVIR (ASV) VS SIMEPREVIR (SMV) + PEGYLATED
INTERFERON ALFA + RIBAVIRIN (PR) IN PREVIOUSLY TREATED JAPANESE PATIENTS CHRONICALLY INFECTED WITH HEPATITIS C
VIRUS (HCV): RESULTS FROM A BAYESIAN META-ANALYSIS
MALNUTRITION IN CIRRHOSIS INCREASES MORBIDITY AND MORTALITY
CAN CURATIVE TREATMENT CONFER SURVIVAL BENEFIT IN ELDERLY PATIENTS WITH HEPATOCELLULAR CARCINOMA ?
VF MAP SCORES (VIRTUAL TOUCH QUANTIFICATION, FASTING PLASMA GLUCOSE, MALE, AGE, PLATELETS) FOR PREDICTION OF
HEPATO-CARCINOGENESIS
PP - 1289
Tomoko Aoki
PP - 1291
Tuul Nyamdavaa
PP - 1294
Natthaya Chuaypen
PP - 1296
Nooralıza Mutalıb
PP - 1299
Dr. Saira Baloch
PP - 1302
Dr. Mohsin Ali Baloch
PP - 1303
Graham Foster
EFFICACY AND SAFETY OF PEGINTERFERON LAMBDA-1A WITH OR WITHOUT DACLATASVIR COMPARED WITH PEGINTERFERON
ALFA-2A, EACH IN COMBINATION WITH RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE
2 OR 3 INFECTION
PP - 1306
Hideo Yoshida
HEPATIC ASCITES TREATMENT WITH NOVEL DIURETICS – VASOPRESSIN V2 RECEPTOR ANTAGONIST (TOLVAPTAN)
PP - 1308
Rezzan Harman
ABSENCE OF CROSS-REACTIVITY BETWEEN TELAPREVIR AND BOCEPREVIR
PP - 1310
Taya Kitiyakara
ALPHA-FETOPROTEIN IS STILL A USEFUL TEST FOR SCREENING HEPATOCELLULAR CARCINOMA IN HEPATITIS B ENDEMIC AREAS
PP - 1311
Yuan-Hung Kuo
COMPARISON STRATEGEMS OF POST-SCREENING MANAGEMENT OF ANTI-HCV-POSITIVE COMMUNITY RESIDENTS: SIMPLE
NOTIFICATION, ACTIVE REFERRAL, OR ACCESSIBLE MEDICAL CARE
PP - 1315
Tami Pilot-Matias
REACTIVATION PRIMARY DISEASE AFTER LDLT IN MONGOLIA
OSTEOPONTIN PROMOTER POLYMORPHISM IS ASSOCIATED WITH THE RISK OF HEPATOCELLULAR CARCINOMA
THE DISEASE PROFILES AND OUTCOME OF HEPATITIS C INFECTION - A SINGLE CENTRE EXPERIENCE
ELECTROLYTES CONCENTRATION IN CIRRHOSIS AND CHRONIC LIVER DISEASE
OCCURRENCE OF ANEMIA IN CHRONIC LIVER DISEASE
CHARACTERIZATION OF RESISTANCE IN HCV GENOTYPE 1B-INFECTED JAPANESE AND WESTERN PATIENTS TREATED WITH AN
INTERFERON- AND RIBAVIRIN-FREE REGIMEN OF OMBITASVIR AND ABT-450/RITONAVIR
DIABETES MELLITUS IS MORE COMMONLY ASSOCIATED WITH IL28B NON-C/C GENOTYPE THAN IN C/C GENOTYPE IN PATIENTS
WITH HCV
PP - 1318
Varun Gupta
PP - 1319
Korn Lertpipopmetha
PP - 1320
Varun Gupta
PP - 1326
Olfat Hammam
THE ROLE OF TNF-α DEPENDENT ANGIOGENESIS IN THE DEVELOPMENT AND PROGRESSION OF HEPATOCELLULAR
CARCINOMA
PP - 1331
Saroj Nazareth
GEOGRAPHIC BARRIERS AND COMPLEX THERAPIES FOR PATIENTS WITH HEPATITIS C CAN BE OVERCOME BY INNOVATIVE AND
EFFECTIVE STRATEGY UTILISING TELEHEALTH
PP - 1346
Haeryoung Kim
IN SITU ANALYSIS OF HTERT MRNA EXPRESSION IN HUMAN HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOMAS
PP - 1351
Yang-Hyon Baek
COMPARISON OF THE ACCURACY BETWEEN LIVER AND SPLEEN ELASTOGRAPHY USING ACOUSTIC RADIATION FORCE IMPULSE AND
OTHER NONINVASIVE TESTS IN PREDICTING THE PRESENCE OF ESOPHAGEAL VARICES
PP - 1353
Rattanaporn Kiatbumrung
PP - 1360
Soon Koo Baik
CLINICAL EFFECT OF APELIN ON PORTAL HYPERTENSION AND PROGNOSIS OF LIVER CIRRHOSIS
PP - 1361
Talat Ayyıldız
LIVER TRANSPLANTATION IN A PATIENT WITH LIVER CIRRHOSIS SECONDARY TO PORTAL HIPERTENSIVE BILIOPATHY: A CASE
REPORT
PP - 1363
Soon Koo Baik
NON-INVASIVE PREDICTION OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION USING TRANSIENT ELASTOGRAPHY AND SPLEEN
DIAMETER/PLATELET COUNT RATIO IN B-VIRAL AND ALCOHOL CIRRHOSIS: EXTERNAL VALIDATION STUDY
PP - 1364
Yoshiyuki Wada
COMPARISON BETWEEN COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING IN THE DIAGNOSIS OF SMALL
HEPATOCELLULAR CARCINOMA
SPECTRUM OF HEPATITIS C PATIENTS AT A TERTIARY CARE CENTRE IN INDIA
THE ASSOCIATION BETWEEN GENETIC VARIATIONS IN PNPLA3 GENE (RS738409) AND SEVERITY OF LIVER FIBROSIS IN THAI
PATIENTS WITH CHRONIC HEPATITIS C
IMPACT OF LIVER DAMAGE AND INFLUENCE OF LIVER FUNCTION RESERVE BY SORAFENIB TREATMENT FOR HEPATOCELLULAR
CARCINOMA PATIENTS WITH CHRONIC LIVER DISEASE
PP - 1369
Talat Ayyıldız
INTRAHEPATIC CHOLESTASIS IN A PATIENT WITH SICKLE CELL ANEMIA: A CASE REPORT
PP - 1372
Hakan Dursun
RETROSPECTIVE ANALYSIS OF PATIENTS WITH HEPATOCELLULAR CARCINOMA(HCC) IN OUR REGION
PP - 1373
Young Mi Hong
COMBINATION OF PEGYLATED-INTERFERON AND RIBAVIRIN AS A PROPHYLACTIC TREATMENT AFTER LIVER TRANSPLANTATION
FOR HEPATITIS C VIRUS : SINGLE CENTER EXPERIENCE WITH HIGH VIROLOGICAL RESPONSE
PP - 1376
Xianli Chen
EXPRESSION OF HBV ANTIGENS IN HEPATOCYTE FOR FIBROSING CHOLESTATIC HEPATITIS B POST LIVER TRANSPLANTATION
PP - 1381
Dilara İnan
EVALUATION OF THE ASSOCIATION BETWEEN IL28B POLYMORPHISMS AND SUSTAINED VIROLOGIC RESPOND IN PATIENT WITH
CHRONIC HEPATITIS C WHO WERE FOLLOWED AT AKDENIZ UNIVERSITY INFECTIOUS DISEASE DEPARTMENT
PP - 1384
Etsuko Iio
A NOVEL GLYCOBIOMARKER: WISTERIA FLORIBUNDA AGGLUTININ+ - MAC-2 BINDING PROTEIN FOR PREDICTING CARCINOGENESIS
AND SURVIVAL OF LIVER CIRRHOSIS PATIENTS
PP - 1386
Chang Wook Kim
PP - 1389
Omar Lopez-Ramos
PP - 1391
Reşat Özaras
IL28B CC GENOTYPE ASSOCIATES HIGHER HCV-RNA LEVELS*
PP - 1392
Reşat Özaras
THE MAIN CHARACTERISTICS OF CHRONIC HEPATITIS C PATIENTS IN TURKEY*
PP - 1394
Ming-Hua Su
CHARACTERISTICS AND THERAPY OF 21 PATIENTS INFECTED HEPATITIS C VIRUS GENOTYPE 6 IN GUANGXI REGION OF CHINA.
PP - 1396
Murat Aladag
LONG-TERM RESULTS OF POST-TRANSPLANTATION HCV TREATMENT
PREVIOUS ACUTE DECOMPENSATION WITHIN ONE YEAR IS ASSOCIATED WITH HIGHER POST-28-DAY MORTALITY IN PATIENTS
WITH ACUTE-ON-CHRONIC LIVER FAILURE
FAT RECEPTOR CD36 POLYMORPHISM (RS1761667) IS ASSOCIATED WITH THE SEVERITY OF LIVER DAMAGE AND LIVER CIRRHOSIS
AMONG HCV-INFECTED PATIENTS FROM WEST MEXICO
PP - 1398
Bo Hyun Kim
IMPROVEMENT IN SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA IN A HEPATITIS B VIRUS ENDEMIC AREA: A
NATIONWIDE COHORT STUDY
PP - 1399
Nuri Okkabaz
ACUTE NECROTIZING PANCREATITIS AFTER TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA
PP - 1400
Hulya Aladag
HEALTHY PREGNANCY AND BIRTH AFTER LIVER TRANSPLANTATION 6 CASES 9 BIRTHS
PP - 1402
Ahmed Ashmawy
PP - 1404
Wei-Lun Tsai
HEPATIC ARTERIAL INFUSION CHEMOTHERAPY VERSUS TRANSCATHETER ARTERIAL EMBOLIZATION FOR PATIENTS WITH HUGE
UNRESECTABLE HEPATOCELLULAR CARCINOMA
PP - 1413
Yu-Jiao Zhang
RISK FACTORS FOR ACUTE LIVER FAILURE IN CHRONIC HEPATITIS B PATIENTS
PP - 1417
Wang-Sheng Ko
NAÏVE AND MEMORY T CELLS PHENOTYPE CHANGE IN CHRONIC HEPATITIS C PATIENTS WITH PEGYLATED INTERFERON-α
WITH RIBAVIRIN TREATMENT
PP - 1431
Seong Hee Kang
COMPARISON OF VARIOUS STAGING SYSTEMS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
PP - 1432
Keisuke Kohno
ABSOLUTE LYMPHOCYTE COUNT AS A PREDICTIVE FACTOR OF PROGNOSIS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
AFTER HEPATECTOMY
PP - 1433
Sook Kyoung Oh
PP - 1439
Minjong Lee
PP - 1446
Hussien Elsiesy
ROLE OF MICROWAVE ABLATION AS AN EFFECTIVE TREATMENT FOR HEPATOCELLULAR CARCINOMA.
OUTCOMES OF EMERGENT AND ELECTIVE INTERVENTION IN CIRRHOTIC PATIENTS WITH GASTRIC OLD BLOOD CLOTS
....
SAFETY OF RIGHT-LOBE LIVING DONOR LIVER TRANSPLANT FROM DONORS WITH GILBERT SYNDROME
THE CLINICAL OUTCOMES AND BILIARY COMPLICATIONS AFTER HYPOFRACTIONATED RADIATION THERAPY IN HEPATOCELLULAR
CARCINOMA
PP - 1447
Hee Chul Park
PP - 1449
Kuniaki Arai
ASSESSING THE FEASIBILITY OF EXISTING CLINICAL GUIDELINES FOR THE MANAGEMENT OF ADVANCED LIVER DISEASE FOR USE IN
RESOURCE-LIMITED SETTINGS
PP - 1453
Hee Chul Park
QUANTITATIVE ANALYSIS OF CORRELATION BETWEEN DOSE TO NORMAL LIVER PARENCHYMA AND RADIOLOGICAL CHANGE ON
FOLLOW-UP GD-EOB-DTPA-ENHANCED HEPATOBILIARY PHASE MAGNETIC RESONANCE IMAGING AFTER STEREOTACTIC ABLATIVE
RADIOTHERAPY FOR HEPATOCELLULAR CARCINOMA
PP - 1454
Bayarmaa Ochirkhuree
PP - 1457
Victoria Sze Min Ekstrom
COST-EFFECTIVENESS OF PEGYLATED INTEFERON AND RIBAVIRIN COMBINATION IN TREATING GENOTYPE 1 HEPATITIS C PATIENTS
IN SINGAPORE.
PP - 1462
Meguru Adachi
THE BENEFIT OF CYSTATIN C IN EVALUATION OF RENAL FUNCTION AND PREDICTION OF PROGNOSIS IN PATIENTS WITH CIRRHOSIS
PP - 1470
M.T. Panlilio
THE SENSITIVITY AND SPECIFICITY OF INHIBITORY CONTROL TEST IN THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY: A
META-ANALYSIS
PP - 1471
Masato Imai
THE FIRST SAFETY REPORT OF HIGH AGED PATIENTS OVER 76 YEARS OLD ADMINISTERED DACLATASVIR AND ASNAPREVIR IN
SINGLE CENTER EXPERIENCE IN JAPAN.
PP - 1473
Heon Young Lee
PP - 1475
Fuat Ekiz
PP - 1478
Fu-Sheng Wang
PP - 1483
Hae Rim Kim
HEPATIC ENCEPHALOPATHY IN MONGOLIAN ADULTS
A CASE OF FALSE POSITIVE ELEVATION OF PIVKA-II IN PATIENT WHO UNDERGONE HEPTECTOMY
FREQUENCY OF DEPRESSION IN PATIENTS WITH CHRONIC HEPATITIS C DURING THE TREATMENT PEGYLATED-INTERFERON
ALPHA/RIBAVIRIN
COMPLEMENT 5A RECEPTOR-MEDIATED NEUTROPHIL DYSFUNCTION IS ASSOCIATED WITH A POOR OUTCOME IN SEPSIS PATIENTS
THE VALIDATION OF HONG KONG LIVER CANCER STAGING SYSTEM AND COMPARISION WITH BARCELONA CLINIC LIVER CANCER
FOR PREDICTION OF SURVIVAL AND TREATMENT IN HEPATOCELLULAR CARCINOMA PATIENTS
PP - 1485
Ira Jacobson
SAFETY AND TOLERABILITY OF DACLATASVIR (DCV) IN PATIENTS WITH CHRONIC HCV INFECTION
PP - 1490
Yu-Dong Wang
PP - 1492
Junya Nuta
ASSESSMENT OF THE MALIGNANT POTENTIAL OF HEPATOCELLULAR CARCINOMA USING KUPFFER-PHASE IMAGES OF CONTRASTENHANCED SONOGRAPHY WITH SONAZOID
PP - 1496
Long Fang
EXPRESSION AND SIGNIFICANCE OF INSULIN RECEPTOR SUBSTRATE 1 (IRS-1) IN HUMAN HEPATOCELLULAR CARCINOMA
PP - 1499
Qing Shao
EFFICACY AND SAFETY OF NEUTRINO THERAPY FOR CHRONIC HEPATITIS C VIRUS GENOTYPE 1B TREATMENT-EXPERIENCED
CHINESE PATIENTS
PP - 1500
Heon Young Lee
PP - 1511
E Hoeben
PP - 1517
Dong Jı
PP - 1519
Jiajia Zhou
PP - 1520
Hitomi Sezaki
EVALUATION OF THE EFFICACY AND LONG-TERM POST-TREATMENT OUTCOMES TO INTERFERON-FREE DUAL ORAL THERAPY WITH
DACLATASVIR AND ASUNAPREVIR
PP - 1521
Myung Jin Oh
A COMPARATIVE STUDY FOR SURVIVAL BENEFITS AND SAFETY OF HEPATIC ARTERIAL INFUSION CHEMOTHERAPY FOR ADVANCED
HEPATOCELLULAR CARCINOMA IN ALCOHOLICS VERSUS NON-ALCOHOLICS
PP - 1523
Bing Li
DOES ETIOLOGY AFFECT PERFORMANCE OF LIVER STIFFNESS MEASURE IN CHINESE IN LIVER FIBROSIS DIAGNOSIS BY TRANSIENT
ELASTOGRAPHY?
COST-EFFECTIVENESS OF SOFOSBUVIR-BASED THERAPY FOR CHRONIC HCV GENOTYPE 1B INFECTION IN CHINA
3 CASES OF PORTAL VEIN THROMBOSIS IN HEPATOCELLULAR CARCINOMA AND LIVER CIRRHOSIS TREATED WITH
ANTICOAGULATION.
SIMEPREVIR EXPOSURE IN ASIAN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1 INFECTION:
RESULTS FROM A POPULATION PHARMACOKINETIC MODEL IN THE PHASE III TIGER STUDY
DUAL DIRECT-ANTIVIRAL AGENTS (DAAS) WITH SOFOSBUVIR PLUS DACLATASVIR FOR CHRONIC HCV TREATMENT-EXPERIENCED
GENOTYPE 1B – IMPACT OF VIRAL KINETICS ON SUSTAINED VIROLOGIC RESPONSE
HEPATITIS C VIRUS CORE PROTEIN UP-REGULATES THE PLURIPOTENCY HOMEOBOX GENE NANOG EXPRESSION BY PI3K/AKT
SIGNALING IN HEPG2 CELLS
PP - 1536
Murat Aladag
PP - 1543
Deeplaxmi Borle
PP - 1544
Zain Elabdeen Sayed
PP - 1546
Anila Kristo
IMPACT OF BODY MASS INDEX (BMI) ON SVR DURING TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C (CHC) WITH
PEGYLATED INTERFERON AND RIBAVIRIN
PP - 1548
Anila Kristo
IMPACT OF BODY MASS INDEX (BMI) ON SVR DURING TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C (CHC) WITH
PEGYLATED INTERFERON AND RIBAVIRIN
PP - 1549
Fiona Mcphee
PP - 1553
Morteza Ghojazadeh
PP - 1554
Murat Aladag
PP - 1555
Fumitaka Suzuki
PP - 1556
Morteza Ghojazadeh
PP - 1557
Koichi Takaguchi
PP - 1561
Haniyeh Ajdari
LONGTERM EFFECTS OF ENTECAVIR THERAPY AND HBIG PROPHYLAXIS ON HBV RELAPSE IN LIVER TRANSPLANT CASES
HEPATIC TUBERCULOSIS IN EXPLANTS OF PATIENTS UNDERGOING LIVER TRANSPLANTATION
NON-INVASIVE PARAMETERS OF OESOPHAGEAL VARICES DIAGNOSIS: WHICH SENSITIVE AND APPLICABLE
ELDERLY AND CIRRHOTIC PATIENTS WITHOUT BASELINE NS5A POLYMORPHISMS IN HCV GENOTYPE 1B HAVE VERY HIGH
SUSTAINED VIROLOGIC RESPONSES TO DACLATASVIR PLUS ASUNAPREVIR
LIFE QUALITY IN PATIENTS WITH HEPATITIS C AND PRESENTATION OF A STRUCTURAL MODEL
IS THERE LONG-TERM VIRAL RELAPSE IN THE CASES THAT UNDERWENT LIVER TRANSPLANTATION FOR HBV AND RECEIVED
TENOFOVIR
EFFECT OF DEMOGRAPHIC AND BASELINE DISEASE CHARACTERISTICS ON THE EFFICACY AND SAFETY OF DACLATASVIR AND
ASUNAPREVIR COMBINATION THERAPY VERSUS TELAPREVIR + PEGYLATED INTERFERON ALFA + RIBAVIRIN THERAPY IN JAPANESE
PATIENTS WITH HCV GENOTYPE 1B INFECTION
THE PERCEPTION OF PATIENTS FROM HEPATITIS C: A PHENOMENOLOGICAL STUDY
EFFICACY AND SAFETY OF DACLATASVIR PLUS ASUNAPREVIR IN JAPANESE PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1B
INFECTION WHO ARE INTERFERON-INELIGIBLE-NAIVE OR INTOLERANT OF INTERFERON-BASED TREATMENT
HEPATITIS C INFECTION IN HIGH RISK POPULATION IN IRAN: A META-ANALYSIS
PP - 1566
Anila Kristo
CLINICAL CONSEQUENCES OF HYPONATREMIA IN LIVER CIRRHOSIS
PP - 1568
Talat Ayyıldız
PP - 1570
Mohamed Kohla
ASSESSMENT OF LIVER FIBROSIS WITH ACOUSTIC RADIATION FORCE IMAGING (ARFI) VERSUS LIVER HISTOLOGY IN PATIENTS WITH
CHRONIC HEPATITIS C: A PILOT STUDY
PP - 1571
Robert Adamczyk
EFFECT OF DACLATASVIR IN COMBINATION WITH ASUNAPREVIR ON THE PHARMACOKINETICS OF A COMBINED ORAL
CONTRACEPTIVE CONTAINING ETHINYL ESTRADIOL AND NORETHINDRONE ACETATE IN HEALTHY WOMEN
PP - 1578
Tarık Akar
TELAPREVIR INDUCED-DRESS SYNDROME WITH SALMONELLA INFECTION
PP - 1582
Ajay Behl
COMPARATIVE EFFICACY AND TOLERABILITY OF COMBINATION TREATMENT WITH DACLATASVIR AND ASUNAPREVIR VERSUS
PEGINTERFERON-ALPHA/RIBAVIRIN-BASED REGIMENS FOR PATIENTS INFECTED WITH GENOTYPE 1B HEPATITIS C VIRUS
PP - 1584
Josephine Anne Lucero
PP - 1588
Guo-Feng Chen
TWELVE-WEEKS SOFOSBUVIR-RIBAVIRIN THERAPY FOR TREATMENT-EXPERIENCED CHRONIC HCV GENOTYPE 2 CHINESE PATIENTS
PP - 1595
Sehyun Cho
EVENT-RELATED POTENTIAL P300 USING AUDITORY “ODDBALL” PARADIGM IN PATIENTS WITH MINIMAL HEPATIC
ENCEPHALOPATHY
PP - 1601
En Xian Sarah Low
PP - 1604
Qing Xie
PP - 1612
Qin Sı
A RARE MICROORGANISM CAUSING PERITONITIS: LISTERIA MONOCYTOGENES
IDIOPATHIC NONCIRRHOTIC PORTAL HYPERTENSION IN A YOUNG FILIPINO FEMALE: A CASE REPORT
RESECTABLE HEPATOCELLULAR CARCINOMA (HCC) IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) – A POORER PROGNOSIS
COMPARED TO HEPATITIS B
EFFECTS OF UNCLEOSIDE ANALOG ON LONG-TERM OUTCOMES OF TREATMENT NAÏVE PATIENTS WITH HBV-RELATED
DECOMPENSATED CIRRHOSIS: A RETROSPECTIVE COHORT STUDY
CONTRAST-ENHANCED ULTRASONOGRAPHY PERFUSION CHARACTERISTICSAND ITS CLINICAL VALUE IN METASTASIS HEPATIC
CARCINOMA
IMPACT OF SUPPORT WITH ERYTHROPOIETIN AND GRANULOCYTE COLONY STIMULATING FACTOR ON OUTCOME OF ANTIVIRAL
THERAPY IN TREATMENT-NAÏVE CHRONIC HEPATITIS C PATIENTS FROM NORTHERN INDIA.
PP - 1617
Nakul Morakhia
PP - 1619
Do Young Kim
PP - 1624
Tomoharu Yamada
PP - 1626
Xiaoning Wu
PP - 1627
Qing Shao
PP - 1630
Nadia Zelinskaia
PP - 1631
Il Han Song
RECURRENCE AND SURVIVAL ANALYSIS AFTER CURATIVE RESECTION OF HEPATOCELLULAR CARCINOMA PATIENTS IN HEPATITIS B
VIRUS-ENDEMIC AREA
PP - 1633
Il Han Song
CARDIAC CIRRHOSIS CAUSED BY CONSTRICTIVE PERICARDITIS: A CASE REPORT
PP - 1641
Ergenekon Karagoz
PP - 1644
Fan Lı
PP - 1649
Tserentsoo Byambaa
PP - 1650
Wonseok Kang
COST-EFFECTIVENESS OF ONE-TIME SCREENIING FOR HCV IN SOUTH KOREA
THE EFFICACY OF TOLVAPTAN AS A TREATMENT FOR REFRACTORY ASCITES IN ADVANCED CIRRHOSIS PATIENTS WITH CHRONIC
KIDNEY DISEASE.
CLINICAL EFFECTS OF ENTECAVIR ALONE VS LAMIVUDINE AND ADEFOVIR COMBINATION ON HBV-RELATED COMPENSATED LIVER
CIRRHOSIS: ONE YEAR PRELIMINARY DATA OF A PROSPECTIVE, MULTICENTER AND NON-INTERVENTION STUDY
BOCEPREVIR-BASED THERAPY FOR TREATMENT-EXPERIENCED CHRONIC HCV CHINESE PATIENTS
THE BIOINFORMATICS DETECTION OF THE POTENTIAL RECOMBINATION SITES IN THE GENOMIC STRUCTURE OF STRAINS OF
GENOTYPE 2 HEPATITIS C VIRUS
THE RELATIONSHIP BETWEEN NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) AND FIBROSIS LEVEL IN CHRONIC HCV PATIENTS
HCV GENOTYPE AND IFNL3 AND IFNL4 IN CHINA
RESULT OF STUDYING IN VITRO EFFECT OF SCUTELLARIA BAICALENSIS GEORGI WHICH IS IN THE CELL OF LIVER CANCER
THE DIAGNOSTIC ACCURACY OF RED CELL DISTRIBUTION WIDTH-TO-PLATELET RATIO IN ASSESSMENT OF LIVER FIBROSIS IN
PATIENTS WITH CHRONIC HEPATITIS B
PP - 1652
Ergenekon Karagoz
CLINICAL USEFULNESS OF MEAN PLATELET VOLUME AS A FIBROSIS MARKER IN CHRONIC HCV PATIENTS
PP - 1655
Hyemin Park
PP - 1657
Fauzi Yusuf
PP - 1660
Anthony W.H. Chan
CLINICOPATHOLOGICAL STUDY OF SCIRRHOUS HEPATOCELLULAR CARCINOMA
PP - 1664
Lidwina Cahyadinata
RENAL DYSFUNCTION IN LIVER CIRRHOTIC PATIENTS AND ITS ROLE TO PREDICT MORTALITY
PP - 1665
Maryam Keshvari
EFFICACY OF 24-WEEK PEGYLATED INTERFERON ALPHA AND RIBAVIRIN COMBINATION THERAPY IN HIGHLY SELECTED PATIENTS
WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION
PP - 1667
Birol Baysal
STANDARD TREATMENT OF CHRONIC HEPATITIS C WITH PEGYLATED INTERFERON AND RIBAVIRIN THERAPY: CAN WE CONTINUE
TO USE?
PP - 1673
Fan Lı
PP - 1674
Yang Jae Yoo
APPLICABILITY OF VARIOUS PROGNOSTIC SYSTEMS FOR HEPATOCELLULAR CARCINOMA PATIENTS RECEIVING TRANSARTERIAL
CHEMOEMBOLIZATION
PP - 1677
Yusuf Kayar
PHYSICIANS HOW MUCH THEY KNOW AND HOW MUCH AWARE OF THE CHRONIC HEPATITIS C: A STUDY WITH QUESTIONNAIRE.
PP - 1680
Maryam Keshvari
PP - 1681
Wei Zhang
SIGNIFICANCE OF INSULIN RESISTANCE ACCORDING TO LIVER STATUS IN CHRONIC HEPATITIS C PATIENTS AFTER PEGINTERFERON
BASED THERAPY
PRECIPITATING FACTOR OF HEPATIC ENCEPHALOPATHY AND FAECAL CALPROTECTIN CONCENTRATION
PROLONGED THEARPY OF CHRONIC HEPATITIC C GENOTYPE 3 DECOMPENSATED CIRRHOSIS WITH SOFOBUVIR-RIBAVIRIN THERAPY
EFFICACY OF PROLONGED TREATMENT WITH PEGYLATED INTERFERON (PEG-IFN) AND RIBAVIRIN IN THALASSEMIC PATIENTS WITH
HEPATITIS C WHO RELAPSED AFTER PREVIOUS PEG-IFN-BASED THERAPY
IMPLICATION OF TYPE 2 DIABETES SUSCEPTIBILITY LOCI IN HEPATITIS C VIRUS INFECTION
TITLE: DOES THE DIFFERENT ETIOLOGICAL PROFILES AFFECT THE OUTCOME OF ACUTE-ON-CHRONIC-LIVER FAILURE IN PEDIATRIC
POPULATION?
PP - 1683
Seema Alam
PP - 1684
Do Young Kim
PP - 1685
Rujipat Wasitthankasem
PP - 1686
Fan Lı
PP - 1690
Ryo Nakagomi
PP - 1695
Birol Baysal
PP - 1699
Guo-Feng Chen
PP - 1701
Murat Aladag
TELAPREVIR BASED TREATMENT SUCCESSFULLY PREVENTS POST TRANSPLANT RELAPSE IN PATIENTS WITH CIRRHOTIC HCV
PP - 1706
Noriyuki Oba
THE OUTCOME OF LAPAROSCOPIC LIVER DISSECTION FOR HEPATOCELLULAR CARCINOMA
PP - 1707
Dong Jı
PP - 1708
Murat Aladag
LONGTERM OUTCOMES OF TELAPREVIR-BASED THERAPY IN PATIENTS WITH CIRRHOTIC HCV
PP - 1710
Birol Baysal
TRIPLE THERAPY OF HCV: MANAGEMENT OF INFECTION OR MANAGEMENT OF SIDE EFFECTS?
COST-EFFECTIVENESS OF ONE-TIME SCREENIING FOR HCV IN SOUTH KOREA
DISTRIBUTION OF HEPATITIS C VIRUS GENOTYPE IN THAILAND
HCV GENOTYPE AND IFNL3 AND IFN4 IN CHINA
INFECTIOUS COMPLICATIONS RELATED TO RADIOFREQUENCY ABLATION FOR LIVER TUMORS: A ROLE OF ANTIBIOTICS
TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR: BEZMIALEM EXPERIENCE
TWELVE-WEEKS SOFOSBUVIR-RIBAVIRIN THERAPY FOR TREATMENT-EXPERIENCED CHRONIC HCV GENOTYPE 2 CHINESE PATIENTS
DUAL DIRECT-ANTIVIRAL AGENTS (DAAS) WITH SOFOSBUVIR PLUS DACLATASVIR FOR CHRONIC HCV TREATMENT-EXPERIENCED
GENOTYPE 1B – IMPACT OF VIRAL KINETICS ON SUSTAINED VIROLOGIC RESPONSE
PP - 1712
Chıkara Ogawa
EASY DETECTION OF LIVER TUMOR USING NEW TECHNOLOGY, VIRTUAL ULTRASOUD SONOGRAPHY
PP - 1714
Ye Wang
PP - 1715
Huiying Rao
PP - 1718
Chhagan Bihari
HEPATOCELLULAR CARCINOMA LEADS TO AN INCREASE IN PLATELET COUNT THAT CONTRIBUTES TO TUMOR GROWTH AND
METASTASIS
PP - 1722
Mustafa Altindis
SIX YEAR DISTRIBUTION PATTERN OF HEPATITIS C VIRUS IN TURKEY: A MULTICENTER STUDY
PP - 1723
Bugra Tolga Konduk
THE COMPARISON OF HEMATOLOGIC PARAMETERS BETWEEN PEGINTERFERON ALPHA-2A AND PEGINTERFERON ALPHA-2B
TREATMENT IN PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C
PP - 1724
Cyriac Abby Philips
QUICK VIRAL RESPONSE IN PATIENTS OF CHRONIC HEPATITIS VIRUS INFECTION PREDICTS OUTCOMES ON ANTIVIRAL THERAPY
EARLIER THAN CONVENTIONAL MONITORING
PP - 1725
Fiona Mcphee
PP - 1727
Jonila Cela
PP - 1735
Tushar Garimella
EXPOSURE-EFFICACY ANALYSIS FOR DACLATASVIR AND ASUNAPREVIR IN DUAL COMBINATION IN NON-JAPANESE AND JAPANESE
SUBJECTS WITH GENOTYPE 1B HEPATITIS C VIRUS INFECTION
PP - 1736
Tushar Garimella
EXPOSURE-SAFETY ANALYSIS FOR ASUNAPREVIR AND DACLATASVIR IN DUAL COMBINATION IN JAPANESE AND NON-JAPANESE
SUBJECTS WITH HEPATITIS C VIRUS INFECTION
PP - 1738
Tushar Garimella
POPULATION PHARMACOKINETIC ANALYSIS OF DACLATASVIR AND ASUNAPREVIR IN NON-JAPANESE AND JAPANESE SUBJECTS
WITH HEPATITIS C VIRUS (HCV) INFECTION
AMINO ACIDS VARIATIONS IN THE NS REGION OF HCV GENOME WERE CORRELATED WITH IFN PLUS RIBAVIRIN COMBINATION
THERAPY
INCREASING GAP BETWEEN HIGH RESPONSE AND INELIGIBLE TO IFN-α IN CHRONIC HEPATITIS C PATIENTS
NEXT-GENERATION SEQUENCING ANALYSIS OF MINOR VARIANTS IN NS5A AND THEIR IMPACT ON SUSTAINED VIROLOGIC
RESPONSES TO DACLATASVIR PLUS ASUNAPREVIR
HEPATOGENOUS DIABETES AND COMPLICATIONS OF LIVER CIRRHOSIS.
PP - 1739
Shigeru Ohtsuru
INFECTIVITY AND CLINICAL SIGNIFICANCE OF DEFECTIVE HEPATITIS C VIRUS CLONES IN CHRONIC HEPATITIS C PATIENTS
PP - 1742
Heidar Sharafi
PP - 1743
Akif Altınbas
PP - 1747
Zobair Younossi
PP - 1751
Nihat Okçu
PP - 1756
Laura E Moreno-Luna
PP - 1766
Talat Ayyıldız
EXPERIENCE OF LIVER TRANSPLANTATION IN ULUDAG UNIVERSITY: PRELIMINARY RESULTS
PP - 1767
Goktug Sirin
BASELINE VITAMIN D LEVEL IS NOT ASSOCIATED WITH SUSTAINED VIROLOGIC RESPONSE TO INTERFERON-BASED ANTIVIRAL
THERAPY IN CHRONIC HEPATITIS C: RESULTS OF SINGLE CENTER EXPERIENCE
PP - 1769
Walid El Moghazy
OUTCOME OF INCIDENTAL HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION
PP - 1771
Ugur Kostakoglu
AN ASSESSMENT OF THE TREATMENT AND SIDE EFFECTS IN COPD AND ASTHMA PATIENTS WITH CHRONIC VIRAL HEPATITIS C
PP - 1783
İftihar Köksal
PP - 1785
Natalia Mazurchik
HIGH TREATMENT SUCCESS RATE WITH PEGYLATED INTERFERON IN IRANIAN PATIENTS WITH CHRONIC HEPATITIS C AND ITS
RELATION TO INTERFERON LAMBDA POLYMORPHISMS
ANTI-HCV SEROPOSITIVITY RATES REMAIN UNDER 0.1% AMONG VOLUNTARY / NON REMUNERATED FIRST TIME BLOOD DONORS
OF TURKISH RED CRESCENT AND THE PATIENTS ADMITTED TO THE HOSPITALS ACROSS TURKEY
INTERFERON- AND RIBAVIRIN-FREE REGIMEN WITH LEDIPASVIR AND SOFOSBUVIR IMPROVES FATIGUE AND VITALITY DURING
TREATMENT AND AFTER ACHIEVING SUSTAINED VIROLOGIC RESPONSE
USEFULNESS OF PROKALSITONIN IN PREDICTING THE DIAGNOSIS AND SEVERITY OF CIRRHOTIC PATIENTS DIAGNOSED WITH
SPONTANEUS BACTERIEL PERITONITIS
THE IMPACT OF OVERWEIGHT AND OBESITY IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION IN A REFERENCE CENTER
ASSESSMENT OF COMBINED SERUM BIOMARKERS AND FIBROSCAN AND DYNAMIC COMPUTED TOMOGRAPHY (CT)
LEVELS OF MICRO-RNA-122, MICRO-RNA-199A, MICRO- RNA-196, MICRO-RNA-491 AND MICRO-RNA-16 AND ANTIVIRAL THERAPY
IN CHRONIC HCV-INFECTION
PP - 1788
Ayhan Balkan
ETIOLOGICAL DISTRIBUTION AND CLINICAL FEATURES OF CIRRHOTIC PATIENTS: SINGLE TERTIARY REFERRAL CENTER EXPERIENCE
PP - 1792
Piyush Sinha
FIRST REPORT OF OVER 150 LIVING DONOR LIVER TRANSPLANTS IN A PUBLIC SECTOR HOSPITAL IN INDIA
PP - 1793
Piyush Sinha
PREOPERATIVE ESTIMATION OF GRAFT WEIGHT USING PORTAL VEIN DIAMETER BEFORE DONOR HEPATECTOMY FOR LIVING
DONOR LIVER TRANSPLANTATION
PP - 1796
Goktug Sirin
ARE INFLAMMATORY MARKERS MORE USEFUL THAN NONINVASIVE FIBROSIS PANELS FOR PREDICTION OF HEPATOCELLULAR
CARCINOMA RECURRENCE?
PP - 1797
Min-Lung Yu
SAFETY AND RAPID PREDICTION OF TREATMENT FUTILITY OF BOCEPREVIR WITH PEGINTERFERON-RIBAVIRIN FOR TAIWANESE
TREATMENT EXPERIENCED HEPATITIS C VIRUS GENOTYPE 1-INFECTEDPATIENTS
PP - 1798
Goktug Sirin
IS FIB-4 INDEX AND GENDER USEFULL FOR PREDICTING THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH
CHRONIC HEPATITIS C : SINGLE CENTER EXPERIENCE
PP - 1801
Nevin Oruc
ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION HELPS TO STAGING AND TREATMENT DECISION OF
HEPATOCELLULAR CARCINOMA
PP - 1804
Fathy Elghamry
PP - 1806
Maryam Keshvari
IMPACT OF ITPA POLYMORPHISMS ON RIBAVIRIN-INDUCED HEMOGLOBIN DECLINE IN PATIENTS WITH CHRONIC HEPATITIS C
INFECTION UNDERWENT TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN
PP - 1807
Heidar Sharafi
HIGH TREATMENT SUCCESS RATE WITH PEGYLATED INTERFERON IN IRANIAN PATIENTS WITH CHRONIC HEPATITIS C AND ITS
RELATION TO INTERFERON LAMBDA POLYMORPHISMS
PP - 1808
Maryam Moini
ADRENAL DYSFUNCTION MAY PLAY A ROLE IN THE PATHOGENESIS OF HYPONATREMIA IN CIRRHOSIS
PP - 1811
Shuntaro Obi
PROGNOSTIC VALUE OF SERUM LEPTIN ∕ ADIPONECTIN RATIO IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
“HYPONATREMIA” IS PROGNOSIS FACTOR OF REFRACTORY ASCITES IN DECOMPENSATED LIVER CIRRHOSIS PATIENTS.
LEFT VENTRICULAR GEOMETRIC REMODELLING AND DIASTOLIC DYSFUNCTION: PROPORTION AND CORRELATION WITH STAGE OF
LIVER DYSFUNCTION SEVERITY
PP - 1822
Prionggo Mondrowinduro
PP - 1826
Taya Kitiyakara
PP - 1828
Yusuf Onlen
PP - 1831
Sebahat Basyigit
RECURRENT CELLULITIS AND SUBCUTAN ABSCESS IN A PATIENT WITH CIRRHOSIS
PP - 1834
Soon Woo Nam
SHORT TERM VIROLOGIC EFFICACIES OF TELBIVUDINE VERSUS ENTECAVIR AGAINST HEPATITIS B-RELATED HEPATOCELLULAR
CARCINOMA
PP - 1838
Jem Ma Ahn
PP - 1840
Dong Hyun Sinn
INCIDENCE RATE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS C PATIENTS WHO ACHIEVED SUSTAINED VIROLOGICAL
RESPONSE
PP - 1841
Joji Yamamoto
INTRAHEPATIC SPLENOSIS MIMICKING HEPATOCELLULAR CARCINOMA, A CASE REPORT
PP - 1843
Hasnain Ali Shah
PARTIAL SPLENIC ARTERY EMBOLIZATION (PSAE) IN CIRRHOSIS IS A SAFE AND USEFUL PROCEDURE
PP - 1845
Ehab Abdel-Atty
RELATION OF INSULIN RESISTANCE AND HEPATOCELLULAR CARCINOMA IN NON-OBESE NON-DIABETIC HEPATITIS C POSITIVE
PATIENTS
PP - 1847
Kimberly Garrison
SOFOSBUVIR POPULATION PHARMACOKINETICS IN JAPANESE SUBJECTS WITH CHRONIC GENOTYPE 2 HCV INFECTION
PP - 1848
Kimberly Garrison
POPULATION PHARMACOKINETIC ANALYSIS OF LEDIPASVIR/SOFOSBUVIR FIXED DOSE COMBINATION TABLET IN JAPANESE
SUBJECTS WITH CHRONIC GENOTYPE 1 HCV INFECTION
WHAT IS THE RIGHT AGE TO START SCREENING FOR HEPATOCELLULAR CARCINOMA IN THAILAND?
A CHRONIC HEPATITIS C PATIENT PRESENTING ATRIOVENTRICULARY BLOC WHILE RECEIVING PEGYLATED INTERFERON AND
CLINICAL APPROACH
PREDICTION OF THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B
THE IMPACT OF ITPA POLYMORPHISMS ON SUSTAINED VIROLOGICAL RESPONSE TO TREATMENT WITH PEGYLATED INTERFERON
AND RIBAVIRIN IN IRANIAN PATIENTS WITH CHRONIC HEPATITIS C INFECTION
PP - 1851
Maryam Keshvari
PP - 1852
Sheng-Nan Lu
CURRENT STATUS OF HEPATOCELLULAR CARCINOMA IN TAIWAN: A NATIONAL-WIDE ANALYSIS
PP - 1860
Ga Won Song
PREDICTING FACTORS HEPATOCELLULAR CARCINOMA PROGRESSION AFTER TRANSARTERIAL CHEMOEMBOLIZATION
PP - 1867
Se Young Jang
TWELVE-YEAR TREATMENT OUTCOMES OF RADIOFREQUENCY ABLATION AS FIRST LINE TREATMENT FOR HEPATOCELLULAR
CARCINOMA IN MILAN CRITERIA : ANALYSIS OF 804 PATIENTS IN A SINGLE CENTER
PP - 1868
Zeliha Asilturk
EPIDEMIOLOGY OF LIVER CIRRHOSIS IN ANKARA: SINGLE CENTRE STUDY
PP - 1870
Falak Naz
PP - 1872
Jung Gil Park
PP - 1877
Seung Up Kim Kim
PP - 1879
Ahmet Metin Karadağ
PP - 1881
Hasnain Ali Shah
PP - 1884
Ramesh Batra
PAY IT FORWARD : PASSING ON THE GIFT OF LIFE
PP - 1885
Huseyin Alkim
OUR TRIPLE THERAPY RESULTS IN TREATMENT-EXPERIENCED CHRONIC HEPATITIS C PATIENTS
SEXUAL DYSFUNCTION IN CIRRHOSIS
LONG-TERM FOLLOW-UP RESULTS OF PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA WHO ACHIEVED COMPLETE
REMISSION AFTER SORAFENIB THERAPY
SERUM DICKKOPF-1 (DKK-1) AS A BIOMARKER FOR THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA
HEPATITIS C GENOTYPES IN SYRIAN REFUGEE PATIENT IN TURKEY
SAFETY AND EFFICACY OF THERAPEUTIC PARACENTESIS IN SPONTAEOUS BACTERIAL PERITONITIS
PP - 1889
Harikumar Nair
HEPATIC OSTEODYSTROPHY IN PRELIVER TRANSPLANT POPULATION: PREVALENCE AND BEARING ON AETIOLOGY AND
FUNCTIONAL PARENCHYMAL RESERVE
PP - 1891
Harikumar Nair
INCIDENCE AND PREDICTORS OF INFECTIONS WITHIN 3 MONTHS POST TRANSPLANT IN LIVING DONOR LIVER TRANSPLANT
RECIPIENTS
PP - 1895
Ching-Sheng Hsu
RISK FACTORS FOR CORONARY ARTERY DISEASES IN CHRONIC HEPATITIS C PATIENTS RECEIVING INTERFERON-BASED THERAPY: A
POPULATION-BASED CASE-CONTROL STUDY IN TAIWAN
PP - 1899
Toshihiro Kawai
EMERGENCY ENDOSCOPIC VARICEAL LIGATION FOLLOWING VARICEAL RUPTURE IN PATIENTS WITH ADVANCED HEPATOCELLULAR
CARCINOMA AND PORTAL VEIN TUMOR THROMBOSIS
PP - 1900
Hui Yi, Sara Cheo
FIRST KNOWN CASE OF BOCEPREVIR INDUCED SEVERE HYPOKALAEMIA
PP - 1901
Phil Ha
DEVELOPMENT OF A SMARTPHONE APPLICATION TO ENABLE REMOTE MONITORING IN THE OUTPATIENT MANAGEMENT OF
CIRRHOTIC ASCITES
PP - 1904
Bora Jin
EFFECT OF THE REVERSION OF NS5A S2204I CELL CULTURE-ADAPTIVE MUTATION ON THE REPLICATION OF HEPATITIS C VIRUS
PP - 1906
Hale Gokcan
PP - 1907
Eun Young Cho
THE SIGNIFICANCE OF CHANGE OF THE MEAN CORPUSCULAR VOLUME (MCV) DURING TREATMENT OF CHRONIC HEPATITIS C
PP - 1910
Akihiro Deguchi
USEFULNESS OF ANGIO CT FOR THE DIAGNOSIS AND TREATMENT OF EARLY HEPATOCELLULAR CARCINOMA
PP - 1912
Ender Serin
PP - 1913
Chen-Hua Liu
PREDICTIVE VALUE OF NON-INVASIVE SERUM MARKERS ON HEPATIC FIBROSIS IN CHRONIC HEPATITIS C PATIENTS
HIGH DOSE ORAL FUROSEMIDE WITH SALT INGESTION IN THE TREATMENT OF REFRACTORY ASCITES OF LIVER CIRRHOSIS
A COMPARISON OF ABBOTT REALTIME HCV GENOTYPE II AND VERSANT-LIPA 2.0 LINE PROBE ASSAYS FOR HEPATITIS C VIRUS
GENOTYPING
THE EFFECT OF PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY FOR CHRONIC HEPATITIS C INFECTION IN
ELDERLY PATIENTS
PP - 1914
Dilek Yildiz Sevgi
PP - 1915
Varun Jain
PP - 1916
Maaz M. Badshah
COMPARISON OF HIV/HBV- AND HIV/HCV-COINFECTED PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
PP - 1917
Caitlin Citti
TRENDS OF HEPATOCELLULAR CARCINOMA (HCC) IN HIV-INFECTED PATIENTS OVER TIME, 1995 – 2013
PP - 1918
Kayoko Sugawara
PP - 1920
Hiroshi Uchıya
PP - 1922
Yohei Fujıı
PP - 1924
Chang Wook Kim
PP - 1930
Harun Erdal
PP - 1933
Tsang En Wang
PP - 1934
Tatsuo Kanda
PP - 1935
Yukiyasu Okamura
EMERGING PATTERNS OF SPONTANEOUS CLEARANCE OF HIGH-LEVEL VIREMIA IN CHRONIC HEPATITIS C
USEFULNESS OF PARTIAL SPLENIC EMBOLIZATION (PSE) FOR PATIENTS WITH FOR PORTAL HYPERTENSION DUE TO LIVER CIRRHOSIS
BALLOON-OCCLUDED TRANSCATEHTER ARTERIAL CHEMOEMBOLIZATION (TACE) AS A PROCEDURE TO IMPROVE THERAPEUTIC
EFFICACY OF MIRIPLATIN FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
THERAPEUTIC STRATEGY FOR PATIENTS WITH LIVER CIRRHOSIS COMPLICATING BLEEDING GASTRIC FUNDAL VARICES
LONG-TERM ENTECAVIR MONOTHERAPY IN TREATMENT-NAÏVE CHRONIC HEPATITIS B PATIENTS FROM A REAL-WORLD CLINICAL
PRACTICE IN KOREA
DIAGNOSTIC ROLE OF DICKKOPF PROTEINS IN HEPATOCELLULAR CARCINOMA
THE CLINICAL EXPERIENCE OF SORAFENIB IN MIDDLE-OLD AND OLDEST-OLD PATIENTS WITH HEPATOCELLULAR CARCINOMA IN A
MEDICAL CENTER OF TAIWAN
SOFOSBUVIR-CONTAINING REGIMENS COULD ERADICATE HCV GT1 AND GT2 FROM JAPANESE PATIENTS
THE RELATIONSHIP BETWEEN THE NEUTROPHIL TO LYMPHOCYTE RATIO AND THE UICC STAGING SYSTEM FOR HEPATOCELLULAR
CARCINOMA AFTER CURATIVE SURGERY
PREVALENCE, ETIOLOGY AND CLINICAL CHARACTERISTICS OF NON-CIRRHOTIC PORTAL HYPERTENSION IN A SOUTH-EAST ASIAN
COHORT
PP - 1938
Pik-Eu Chang
PP - 1941
Hyun Yang
PP - 1943
Dimitrios Dimitroulopoulos
PP - 1944
Shinpei Sato
PP - 1946
Dimitrios Dimitroulopoulos
PP - 1949
Nikhil Patel
VALUE OF ALPHA-FETO PROTEIN IN HEPATOCELLULAR CARCINOMA DETECTION
PP - 1952
Murat Kekilli
IS PREALBUMIN RATHER THAN ALBUMIN A MORE SENSITIVE INDICATOR OF LIVER DYSFUNCTION IN CHILD A CIRRHOSIS ?
PP - 1954
Chern Hao Chong
PP - 1955
Hae Lim Lee
PP - 1956
Ahmed Lutful Moben Moben
PP - 1958
Shigemune Bekki
PP - 1963
Long Chen
ETIOLOGICAL ROLES OF DIABETES, BMI AND PAST HEPATITIS B INFECTION IN THE DEVELOPMENT OF NON-B NON-C, NONALCOHOLIC HEPATOCELLULAR CARCINOMA
THE CHANGES OF HCV GENOTYPE DISTRIBUTION IN GREECE DURING THE LAST 12 YEARS
PERCUTANEOUS URTRASOUND-GUIDED RADIOFREQUENCY ABLATION FOR EXTRAHEPATIC NEOPLASMS.
DEMOGRAPHIC, EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) IN
SOUTHEASTERN EUROPE
POST LIVER TRANSPLANT HYPERGLYCAEMIA REQUIRING INSULIN TREATMENT IS ASSOCIATED WITH INCREASED RISK OF NEW
ONSET DIABETES AFTER TRANSPLANT (NODAT)
CONSECUTIVE INCREMENT OF SERUM ALPHA-FETO PROTEIN LEVEL IS A USEFUL SURROGATE MARKER IN PREDICTING
HEPATOCELLULAR CARCINOMA IN LIVER CIRRHOSIS PATIENTS
GRADE-II-III OESOPHAGEAL VARICES IN CIRRHOTIC PATIENTS CAN BE PREDICTED BY MEASURING LIVER STIFFNESS WITH
FIBROSCAN
PRELIMINARY STUDY OF FACTORS ABOUT THE EFFECT OF TOLVAPTAN TO LIVER CIRRHOSIS
A LONG NON-CODING RNA, N334975, IS UP-REGULATED IN TGF-βTREATED HUMAN HEPATIC STELLATE CELL
PP - 1968
Memduh Sahin
HEMATOLOGIC PARAMETERS IN THERAPY WITH PEGINTERFERONE ALFA- 2B OF HEPATITIS C SUBJECTS DURING
BUPRENORPHINE SUBSTITUTION FOR HEROIN ADDICTION (ONE YEAR RESULTS OF A SINGLE CENTER IN TURKEY)
PP - 1973
Amrısh Sahney
EARLY PLEURICENTESIS PREDICTS SURVIVAL IN CIRRHOTICS WITH SPONTANEOUS BACTERIAL EMPYEMA.
PP - 1974
Amrısh Sahney
THE MODEL FOR CRITICALLY ILL CIRRHOTICS (MCIC): A NOVEL PROGNOSTIC SCORE FOR PREDICTING MORTALITY IN CRITICALLY ILL
CIRRHOTICS ADMITTED TO ICU.
PP - 1975
Ching-Lung Lai
SOFOSBUVIR PLUS RIBAVIRIN FOR 12, 16 OR 24 WEEKS RESULTS IN SUSTAINED VIROLOGIC RESPONSE OVER 97% IN GENOTYPE 1
AND 6 HCV INFECTION IN HONG KONG
PP - 1984
Hale Gokcan
IMPACT OF PORTAL VEIN THROMBOSIS IN THE SURVIVAL OF CIRRHOSIS PATIENTS
PP - 1986
Bülent Aydınlı
LIVER TRANSPLANTATION FOR INCURABLE ALVEOLAR ECHINOCOCCOSIS: AN EARLY REPORT OF 30 CASES FROM AN ENDEMIC
REGION IN TURKEY
PP - 1987
Sule Poturoglu
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA DESPITE SUCCESSFUL ANTIVIRAL TREATMENT IN HEPATITIS C-RELATED LIVER
CIRRHOSIS: CASE REPORT
PP - 1991
Buyanjargal Shagdarsuren
PP - 2002
Kerstina Boctor
SPLEEN STIFFNESS, LIVER STIFFNESS, AND APRI, ALONE OR IN COMBINATION, ARE EQUALLY PREDICTIVE FOR THE PRESENCE OF
PORTAL HYPERTENSION.
PP - 2004
Huiying Rao
GOOD VIRAL RESPONSE IN CHINESE CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON α-2A PLUS
RIBAVIRIN UPON RELAPSE
PP - 2007
Hyun Yang
METRONOMIC CHEMOTHERAPY COMPARED WITH CONVENTIONAL TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN
PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA WITH POOR LIVER FUNCTION.
PP - 2010
Huiying Rao
A PROSPECTIVE, RANDOMIZED, OPEN LABEL, MULTICENTER STUDY ON RE-TREATMENT FOR NON-RESPONSIVE CHINESE CHRONIC
HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON α-2A PLUS RIBAVIRIN
USEFULNESS OF CONTRAST-ENHANCED ULTRASOUND WITH PERFLUOROBUTANE MICROBUBBLE IN THE DIAGNOSIS OF
RECURRENT HEPATOCELLULAR CARCINOMA AFTER RADICAL TREATMENT
THE ROLE OF 18F-FDG PET-CT IN PREDICTION OF PROGRESSION-FREE SURVIVAL AFTER YTTRIUM-90 RADIOEMBOLIZATION IN
PATIENTS WITH HEPATOCELLULAR CARCINOMA
PP - 2015
Wonseok Kang
PP - 2018
Mehmet Bayram
PP - 2019
Hikmet Akkız
ASSOCIATION BETWEEN IL28B GENE RS8099917 POLYMORPHISM AND SVR IN TURKISH PATIENTS WITH HEPATITIS C VIRUS
GENOTYPE 1
PP - 2020
Jonathan Lee
VITAMIN D DEFICIENCY AMONG LIVER TRANSPLANT PATIENTS: PREVALANCE, PREDICTIVE FACTORS, ADVERSE OUTCOMES AND
REPLACEMENT DOSES REQUIRED
PP - 2021
Chia-Yen Dai
LONG TERM SURVIVAL ANALYSIS OF PATIENTS WITH SINGLE HEPATOCELLULAR CARCINOMA
PP - 2023
Dae Sung Lee
PARTIAL SPLEEN EMBOLIZATION IN PATIENTS WITH THROMBOCYTOPENIA ACCOMPANIED BY LIVER CIRRHOSIS, COMPARED TO
CONTROL GROUP
PP - 2027
Ayako Mine
PP - 2036
Drnidasajid Sajid
PP - 2039
Mohammad Faiz Ahmad
Khondaker
PP - 2041
Banu Bayraktar
PP - 2043
Kai Deng
PP - 2046
Dr Muhammad Imran Imran
FIRST WEEK HCV RNA LEVEL UNDER THE PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT PREDICTS SUSTAINED VIROLOGICAL
RESPONSE
THE PRELIMINARY STUDY OF LONG TERM ADMINISTRATION OF TOLVAPTAN FOR REFRACTORY ASCITES DUE TO LIVER CIRRHOSIS
PEGYLATED INTERFERON RELATED THYROIDAL DYSFUNCTION IN CHRONIC HEPATITIS C PATIENTS
PREDICTION OF OESOPHAGEAL VARICES BY MEASURING BLOOD AMMONIA LEVEL IN CIRRHOTIC PATIENTS.
CONFIRMATION AND EVALUATION OF ELECSYS ANTI-HCV II ASSAY POSITIVITIES BY INNO-LIA HCV SCORE AND HCV-RNA ASSAYS
MONOCLONAL ANTIBODIES TARGETING NOVEL EPITOPES OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN PRECLUDES VIRUS
INFECTION IN VITRO
FREQUENCY OF THYROIDAL DYSFUNCTION IN CHRONIC HEPATITIS C SERO POSITIVES
DETECTION OF NS5B C316N—A RESISTANT MUTATION TO SOFOSBUVIR IN TREATMENT-NAÏVE GENOTYPE 1B HCV INFECTED
PATIENTS USING ULTRA-DEEP SEQUENCING
PP - 2047
Ye Wang
PP - 2048
Premashis Kar
EXPRESSION ANALYSIS OF PROTEINS INDUCING INTERFERON IN CHRONIC HEPATITIS C PATIENTS
PP - 2050
Wei Zhang
IDENTIFICATION OF SUSCEPTIBILITY LOCI FOR TYPE 2 DIABETES IN HEPATITIS C VIRUS INFECTION
PP - 2051
Murat Pekgöz
PP - 2052
Cuneyt Kayaalp
PP - 2055
Hale Gokcan
CALCINEURIN INHIBITOR INDUCED PAIN SYNDROME IN LIVER TRANSPLANT PATIENT
PP - 2056
Gloria Chan
ASIAN PATIENTS UNDERGOING COLONOSCOPY ASSESSMENT FOR PRE-LIVER TRANSPLANT WORK UP WERE FOUND TO HAVE A
HIGHER INCIDENCE OF COLONIC POLYPS AND ADVANCED NEOPLASIA THAN GENERAL POPULATION
PP - 2058
Pisit Tangkijvanich
PP - 2059
Dipu Bharali
PP - 2061
Nobuhito Taniki
RADIOFREQUENCY ABLATION IN VERY ELDERLY PATIENTS WITH LIVER TUMORS
PP - 2065
Awinash Kumar
N-ACETYL CYSTEINE IS INEFFECTIVE IN PREVENTING ISCHEMIC HEPATITIS FOLLOWING VARICEAL BLEED IN CIRRHOTICS: INTERIM
ANALYSIS OF A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL
PP - 2067
Tanvi Khera
THE EFFECTIVITY AND SAFETY OF TRIPLE THERAPY (TELAPREVIR, PEGILE-INTERFERON ALFA AND RIBAVIRIN) IN PATIENTS WITH
CHRONIC HEPATITIS-C: A SINGLE CENTER EXPERIENCE FROM TURKEY
RETAINED FOREIGN BODY IN A TRANSPLANTED LIVER
THE PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 3 (PNPLA3) POLYMORPHISM IN HEPATOCELLULAR
CARCINOMA: RELATION WITH THE ETIOLOGY OF LIVER DISEASE
EXPRESSION AND SIGNIFICANCE OF MICRO RNA-21 IN HEPATOCELLULAR CARCINOMA
STUDYING EVOLUTIONARY CONSTRAINTS ON HEPATITIS C VIRUS REPLICATION VIA ANALYSIS OF SERINE CODON USAGE
PP - 2069
Syed Abul Foez Foez
VALUE OF ASCITIC FLUID CHOLESTEROL TO DIFFERENTIATE CIRRHOTIC FROM NON-CIRRHOTIC ASCITES.
PP - 2070
M A Rahim
PP - 2076
Rakhi Maiwall
AKI PERSISTENCE AT 48 HOURS PREDICTS MORTALITY IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE PROVIDED THE PEAK
CREATININE IS ABOVE 1.14MG/DL
PP - 2078
Firdevs Topal
THE EFFECT OF INSULIN RESISTANCE ON ERVR IN CHRONIC HEPATITIS C PATIENTS UNDER TREATMENT WITH TELEPREVIR
TREATMENT
PP - 2079
Sabite Kacar
DEVELOPMENT OF MALIGNANCY AFTER LIVER TRANSPLANTATION: A CASE SERIES
PP - 2081
Sabite Kacar
DEVELOPMENT OF MALIGNANCY AFTER LIVER TRANSPLANTATION: A CASE SERIES
PP - 2086
Fatma Ekşi Polat
PP - 2090
Segey Lepkov
THE EFFECTIVENESS OF THERAPY IN PATIENTS WITH EXTRAHEPATIC MANIFESTATIONS OF CHRONIC HEPATITIS C - HEPATITIS C
INDOLENT LYMPHOMA ASSOCIATED (IL + C)
PP - 2092
Segey Lepkov
THE EFFECTIVENESS OF THERAPY IN PATIENTS WITH EXTRAHEPATIC MANIFESTATIONS OF CHRONIC HEPATITIS C - HEPATITIS C
INDOLENT LYMPHOMA ASSOCIATED (IL + C)
PP - 2093
Kenich Kitada
EFFICACY AND SAFETY OF SIMEPREVIR PLUS REDUCED DOSAGE OF PEGYLATED INTERFERONα2B AND RIBAVIRIN IN ELDERLY
PATIENTS WITH TREATMENT-EXPERIENCED HCV GENOTYPE 1B.
PP - 2094
Kazutaka Kurokohchi
PP - 2095
Yu Rim Lee
CORRELATION OF ASCITIC FLUID AND VENOUS BLOOD ELECTROLYTES IN CIRRHOTIC PATIENTS
CHANGING OF HEPATITIS C GENOTYPES IN ISTANBUL
SEQUENTIAL THERAPY (PEI-RFA → PELIT → IVR) FOR LARGE SIZED ADVANCED HEPATOCELLULAR CARCINOMA.
PROGNOSTIC FACTORS AFFECTING TREATMENT OUTCOMES OF ACUTE VARICEAL BLEEDING IN PATIENTS WITH HEPATOCELLULAR
CARCINOMA: A SINGLE CENTER PROSPECTIVE STUDY
PP - 2098
Rikako Kinoshita
CLINICOPATHOLOGIC FEATURE OF HEPATOCELLULAR CARCINOMA SURVIVING FOR MORE THAN TEN YEARS
PP - 2103
Tae Yoo
PP - 2104
Eslam Habba
PP - 2108
Mohamed Elateek
PP - 2119
Hussien Elsiesy
PP - 2124
Xuqing Zhang
CHANGING ETIOLOGIES AND OUTCOME OF LIVER FAILURE IN SOUTHWEST CHINA
PP - 2125
Emine Parlak
THE RELATIONSHIP BETWEEN TUMOR NECROSIS FACTOR ALFA LEVEL AND HEPATIC ACTIVITY INDEX IN PATIENTS WITH CHRONIC
HEPATITIS C
PP - 2132
Şükrü Arslan
A RARE CAUSE OF LIVER FAILURE AFTER RIGHT HEPATECTOMY: PARTIAL LEFT LOBULE ROTATION
PP - 2138
Xheni Deda
ETIOLOGY AND NATURAL COURSE OF END-STAGE LIVER DISEASE IN THE REAL WORLD SETTING
PP - 2141
Yu-Yong Jiang
PP - 2142
Hanefi Cem Gul
RESEARCH OF THE ASSOCIATION BETWEEN PARAOXONASE-1 GENE POLYMORPHISM AND RESPONSE FOR THE MEDICAL
TREATMENT OF THE PATIENTS WITH CHRONIC HEPATITIS C INFECTION
PP - 2146
Meltem Ergun
EFFICACY AND LONG TERM SAFETY OF GASTRIC VARICEAL OBLITERATION USING N-BUTYL-2-CYANOACRYLATE IN PATIENTS WITH
ACUTE GASTRIC VARICEAL HEMORRHAGE: AN EXPERIENCE FROM TURKEY
IMPACT OF HBV DNA LEVEL & ANTIVIRAL AGENT ON THE RECURRENCE OF PATIENTS AFTER LIVER RESECTION FOR HEPATITIS B
VIRUS–RELATED HEPATOCELLULAR CARCINOMA
RISK FACTORS FOR RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER RADIOFREQUENCY ABLATION IN A COHORT OF
EGYPTIAN PATIENTS WITH HEPATITIS C VIRUS-INDUCED CIRRHOSIS: A DOUBLE CENTER ANALYSIS.
ASSESSMENT OF PATHOLOGICAL RESPONSE IN NON VIRULOGICAL RESPONDERS TO IFN/REBAVIRIN THERAPY
PLASMAPHARESIS, INTRAVENOUS IMMUNOGLOBULIN AND RITUXIMAB SUCCESSFULLY TREAT RECURRENT PROGRESSIVE FAMILIAL
INTRAHEPATIC CHOLESTASIS TYPE 2 AFTER LIVER TRANSPLANTATION
A CASE REPORT ABOUT RIBAVIRIN INDUCED EXCESS IRON ACCUMULATION IN CHRONIC HEPATITIS C
PP - 2148
Ahmad Nawaz
RIFAXIMIN VERSUS PLACEBO IN REDUCING THE RISK OF CLINICALLY OVERT HEPATIC ENCEPHALOPATHY RECURRENCE IN PATIENTS
HAVING CIRRHOSIS OF LIVER.
PP - 2149
Ahmet Yozgat
EXPERIENCE OF HCV TREATMENT IN LAST TWO YEARS AT ANKARA NUMUNE EDUCATION AND RESEARCH HOSPITAL
PP - 2150
Hakki Polat
SPLENIC EMBOLIZATION MAY BE AN OPTION TO OVERCOME THROMBOCYTOPENIA INTERFERING WITH TRIPLE THERAPY IN HCV (+)
CIRRHOTIC PATIENTS: A CASE REPORT.
PP - 2164
Andri Sanityoso
ASSOCIATION BETWEEN SNP IL-28B AND SUSTAINED VIROLOGICAL RESPONSE AND ITS RELATION WITH EXPRESSION OF
INTERFERON LAMBDA AND INTERFERON LAMBDA RECEPTOR IN LIVER TISSUES OF CHRONIC HEPATITIS C PATIENTS TREATED WITH
PEGYLATED INTERFERON-Α2 AND RIBAVIRIN
PP - 2165
Chih-Ming Lin
CHADS2 SCORES IN THE PREDICTION OF ISCHEMIC STROKE IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION
PP - 2166
Hikmet Akkız
ASSOCIATION BETWEEN ITPA GENE RS1127354 POLYMORPHISM AND RBV-INDUCED ANEMIA IN TURKISH PATIENTS WITH
HEPATITIS C VIRUS GENOTYPE 1
PP - 2171
Güray Can
NON-INVASIVE PREDICTORS OF ESOPHAGEAL VARICES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS ASSOCIATED CIRRHOSIS
PP - 2175
Preetam Nath
CLINICAL CHARACTERIZATION AND PREVALENCE OF METABOLIC RISK FACTORS IN PATIENTS WITH CRYPTOGENIC CIRRHOSIS: A
CASE CONTROL STUDY
PP - 2178
Gokhan Gungor
PP - 2182
Inna Vengher
THE IMPACT OF THE AFFECTIVE STATE ON THE SATISFACTION REGARDING TREATMENT OUTCOMES IN PATIENTS WITH CHRONIC
VIRAL HEPATITIS
PP - 2183
Hikmet Akkız
EFFICACY OF PEGYLATED INTERFERON ALPHA AND RIBAVIRIN TREATMENT ON THE RISK OF HEPATOCELLULAR CARCINOMA IN
PATIENTS WITH CHRONIC HEPATITIS C: A PROSPECTIVE STUDY
PP - 2185
Shilei Xu
POTENTIAL EFFECTS OF ANEMIA IN HEPATORENAL SYNDROME
THE INFLUENCE OF SIROLIMUS-BASED IMMNOSUPPRESSION IN LIVER TRANSPLANTATION FOR PATIENTS WITH HEPATOCELLULAR
CARCINOMA IN THE MILAN CRITERIA
PP - 2186
Natalia Taran
LIVER TRANSPLANT EXPERIENCE IN REPUBLIC OF MOLDOVA
PP - 2188
Aysun Yalci
PP - 2189
Shilei Xu
SURVIVAL ANALYSIS OF SIROLIMUS-BASED IMMNOSUPPRESSION IN LIVER TRANSPLANTATION FOR PATIENTS WITH
HEPATOCELLULAR CARCINOMA BEYOND UCSF CRITERIA
PP - 2195
M Yakut
DIAGNOSTIC AND PROGNOSTIC ROLE OF SERUM IL-6 IN MALIGN TRANSFORMATION OF LIVER CIRRHOSIS
PP - 2197
N. Ormeci
PP - 2205
Ahmed Abdulghany
PP - 2207
Aysun Yalci
PP - 2208
Dılıp Sharma
PP - 2214
Simten Malhan
PP - 2215
Yinjie Gao
PP - 2220
Ming-Lun Yeh
PP - 2222
Ibrahim Mostafa
MUCORMYCOSIS IN LIVER TANSPLANT RECIPIENTS:CASE REPORT
IS ETIOLOGIC PROFILE OF THE LIVER CIRRHOSIS DIFFERENT THAN WORLDWIDE IN TURKEY?
ESOPHAGEAL VARICES AS AN ADDITIONAL SITE FOR PLATELET SEQUESTRATION, EFFECT OF VARICEAL ERADICATION ON PLATELET
COUNT
SUSTAINED VIROLOGICAL RESPONSE WITH SHORT-TERM TELAPREVIR TREATMENT: A CASE REPORT
VITAMIN D DEFICIENCY IN PATIENTS OF LIVER CIRRHOSIS: A NEPALESE STUDY
ECONOMIC BURDEN OF CHRONIC HEPATITIS C AND ITS COMPLICATIONS IN TURKEY
CHANGES IN FOXP3+ REGULATORY T CELLS AND INTERLEUKIN- 17-PRODUCING T HELPER CELLS IN DE NOVO HEPATITIS B VIRUS
INFECTION AFTER ORTHOTOPIC LIVER TRANSPLANTATION
PERSONALIZED THERAPY OF CHRONIC HEPATITIS C AND B CO-INFECTED PATIENTS WITH PEGYLATED INTERFERON PLUS RIBAVIRIN:
A RANDOMIZED STUDY
PILOT STUDY TO DETERMINE THE EFFICACY AND SAFETY OF COMBINING BOCEPREVIR WITH PEGINTERFERON ALFA-2B AND
RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 4 CHRONIC HEPATITIS C INFECTION
PP - 2225
Surim Park
PROTECTIVE EFFECTS OF NICOTINE AGAINST ACETAMINOPHEN-INDUCED HEPATOTOXICITY
PP - 2228
Shalini Bansal*
PP - 2233
Ramin Farajpour
PP - 2237
Zuxiong Huang
PP - 2241
Tarek Korah
TREATMENT OF REFRACTORY ASCITES
PP - 2243
Huiguo Ding
MEASUREMENT OF SERUM PROCALCITONIN LEVELS FOR THE EARLY DIAGNOSIS OF SPONTANEOUS BACTERIAL PERITONITIS IN
PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS
PP - 2244
Resat Ozaras
REAL LIFE CHARACHTERISTICS OF HEPATITIS C VIRUS TREATMENT: TURKEY’S RESULTS OF PEGBASE STUDY
PP - 2245
İftihar Köksal
BASELINE CHARACHTERISTICS OF HEPATITIS C VIRUS PATIENTS IN TURKEY: THE RESULTS OF PEG-BASE COHORT
PP - 2246
Mehmet Demir
REAL LIFE SAFETY DATA OF TELAPREVIR-CONTAINING HEPATITIS C VIRUS THERAPY IN TURKEY: THE RESULTS OF PEG-BASE COHORT
PP - 2247
Mara Panlilio
CLINICAL PROFILE, PROGNOSTIC FACTORS, AND SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA IN TWO PHILIPPINE
TERTIARY CENTERS
HEPATOCELLULAR CARCINOMA MOLECULAR SUBCLASS AS A POTENTIAL PREDICTIVE BIOMARKER OF DRUG RESPONSE
HEPATITIS C VIRUS ASSOCIATED MIXED CRYOGLOBULINAEMIA
ACUTE KIDNEY INJURY IN HEPATITIS B-RELATED ACUTE-ON-CHRONIC LIVER FAILURE WITHOUT PREEXISTING LIVER CIRRHOSIS